As of 2025-06-17, the EV/EBITDA ratio of Infinity Pharmaceuticals Inc (INFI) is 0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INFI's latest enterprise value is -16.29 mil USD. INFI's TTM EBITDA according to its financial statements is -41.62 mil USD. Dividing these 2 quantities gives us the above INFI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 13.7x | 13.0x |
| Forward P/E multiples | 20.5x - 21.5x | 21.0x |
| Fair Price | (25.72) - (17.00) | (21.20) |
| Upside | -57629.0% - -38140.8% | -47526.7% |
| Date | EV/EBITDA |